Alter Pharma, a Belgian pharmaceutical group, received an investment from The Riverside Company.
Belfius Bank, ING Belgium and NIBC Bank provided financing for the transaction, whose amount was not disclosed.
The company will use the proceeds to accelerate growth.
Led by Stijn Van Rompay, founder and CEO, Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships.
Alter Pharma’s products serve a wide range of therapeutic areas, including oncology, gastroenterology, pain, cardiology, neurology and others to follow.